Schoeftner Stefan

Stefan Schoeftner

Staff/Student ID number:

22775

Title:

Prof.

Phone:

040 558 8743

Email:

Personal details (contacts, publications, cv, etc...)

Position:

Associate professor

Field:

Molecular Biology

Activities:

Executive Board - Lecturer Representative

Department's Board - Member

Boards of Studies - Coordinator

Boards of Studies - Member

Doctoral Studies Boards - Member

Doctoral Studies Boards - External Expert

Teaching staff - Teaching staff

Research Group - Member

Programme Description	Position
SM51 - BIOLOGICAL SCIENCES AND TECHNOLOGIES	Boards of Studies - Member
PHD02 - MOLECULAR BIOMEDICINE - CYCLE XXX	Doctoral Studies Boards - Member
PHD02 - MOLECULAR BIOMEDICINE - CYCLE XXXI	Doctoral Studies Boards - Member
PHD02 - MOLECULAR BIOMEDICINE - CYCLE XXXII	Doctoral Studies Boards - Member
PHD02 - MOLECULAR BIOMEDICINE - CYCLE XXXIII	Doctoral Studies Boards - Member
PHD02 - MOLECULAR BIOMEDICINE - CYCLE XXXIV	Doctoral Studies Boards - Member
PHD02 - MOLECULAR BIOMEDICINE - CYCLE XXXVII	Doctoral Studies Boards - External Expert
PHD02 - MOLECULAR BIOMEDICINE - CYCLE XXXVIII	Doctoral Studies Boards - Member
DR02 - MOLECULAR BIOMEDICINE - CYCLE XXXIX	Doctoral Studies Boards - Member
SM53 - FUNCTIONAL GENOMICS	Boards of Studies - Coordinator

Research Groups

Research Group	Research Area	Research Strand
Non-coding RNA and genomic stability (Prof. Schoeftner)	Biomedicine	Molecular oncology

Progetti

Research Project	Position	Status of Research Project
10% RICERCA DOTT. ALESSANDRO FERRANDO - PRIMI 18 MESI AIRC SCHOEFTNER; POI UNITS	Research projects - Scientific Actor;	Closed
10% RICERCA DOTT. SSA CHIARA BONCRISTIANI - PRIMI 18 MESI AIRC SCHOEFTNER; POI UNITS	Research projects - Scientific Actor;	Closed
10% FRAMARINI ALESSANDRO - 100% SCHOETFNER RICNAZSCHOEFTNERAIRC-20 primi 18 mesi; 100% UNITS restanti 18 mesi	Research projects - Scientific Actor;	Active
National Center for Gene Therapy and Drug Based on RNA Technology	Research projects - Participant;	Active
National Center for Gene Therapy and Drug Based on RNA Technology - ATTIVITA' NON RENDICONTABILI	Research projects - Participant;	Active
Prot. 2022KWLYAL - Reprogramming the ovarian tumor microenvironment by interfering with epigenetic self-renewal circuits centered on OCT4 and trans-acting OCT4 pseudogene lncRNA	Research projects - Scientific Actor;	Active
Prot. P2022RSP2C - The role of liquid-liquid phase separation in suppressing R-loop mediated activation of innate immunity in cancer	Research projects - Scientific Actor;	Active
10% GIAQUINTO MICHELE - 50% COMMISSIONE EUROPEA e 50% MUR	Research projects - Scientific Actor;	Active
10% PARLANTE ANDREA - 50% D40-RPRIN22SCHOE_01 - 50% MUR	Research projects - Scientific Actor;	Active

Last update: 05-23-2025 - 23:30

Hide/Show

Servizi online

---